U.S. ITC ends ‘Botox brawl’ in Medytox’s favor, but reduces penalty

After a two-year investigation, the U.S. International Trade Commission has made a final determination in favor of Medytox in its high-profile “Botox brawl” with Daewoong Pharmaceutical.
( read original story …)


Advertisement